Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Verónica Gómez.
Eurosurveillance | 2017
Marc Rondy; Amparo Larrauri; Itziar Casado; Valeria Alfonsi; Daniela Pitigoi; Odile Launay; Ritva Syrjänen; Giedre Gefenaite; Ausenda Machado; Vesna Višekruna Vučina; Judith Krisztina Horváth; Iwona Paradowska-Stankiewicz; Sierk Marbus; Alin Gherasim; Jorge Díaz-González; Caterina Rizzo; Alina Ivanciuc; Florence Galtier; Niina Ikonen; Aukse Mickiene; Verónica Gómez; Sanja Kurečić Filipović; Annamária Ferenczi; Monika R Korcinska; Rianne van Gageldonk-Lafeber; Marta Valenciano
We conducted a multicentre test-negative case–control study in 27 hospitals of 11 European countries to measure 2015/16 influenza vaccine effectiveness (IVE) against hospitalised influenza A(H1N1)pdm09 and B among people aged ≥ 65 years. Patients swabbed within 7 days after onset of symptoms compatible with severe acute respiratory infection were included. Information on demographics, vaccination and underlying conditions was collected. Using logistic regression, we measured IVE adjusted for potential confounders. We included 355 influenza A(H1N1)pdm09 cases, 110 influenza B cases, and 1,274 controls. Adjusted IVE against influenza A(H1N1)pdm09 was 42% (95% confidence interval (CI): 22 to 57). It was 59% (95% CI: 23 to 78), 48% (95% CI: 5 to 71), 43% (95% CI: 8 to 65) and 39% (95% CI: 7 to 60) in patients with diabetes mellitus, cancer, lung and heart disease, respectively. Adjusted IVE against influenza B was 52% (95% CI: 24 to 70). It was 62% (95% CI: 5 to 85), 60% (95% CI: 18 to 80) and 36% (95% CI: -23 to 67) in patients with diabetes mellitus, lung and heart disease, respectively. 2015/16 IVE estimates against hospitalised influenza in elderly people was moderate against influenza A(H1N1)pdm09 and B, including among those with diabetes mellitus, cancer, lung or heart diseases.
Eurosurveillance | 2017
Marc Rondy; Alin Gherasim; Itziar Casado; Odile Launay; Caterina Rizzo; Daniela Pitigoi; Aukse Mickiene; Sierk Marbus; Ausenda Machado; Ritva Syrjänen; Iva Pem-Novose; Judith Krisztina Horváth; Amparo Larrauri; Jesús Castilla; Philippe Vanhems; Valeria Alfonsi; Alina Ivanciuc; Monika Kuliese; Rianne van Gageldonk-Lafeber; Verónica Gómez; Niina Ikonen; Zvjezdana Lovric; Annamária Ferenczi; Alain Moren
In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65–79-year-olds and 13% (95% CI: −15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.
WOS | 2017
Marc Rondy; Amparo Larrauri; Itziar Casado; Valeria Alfonsi; Daniela Pitigoi; Odile Launay; Ritva Syrjänen; Giedre Gefenaite; Ausenda Machado; Vesna Višekruna Vučina; Judith Krisztina Horváth; Iwona Paradowska-Stankiewicz; Sierk Marbus; Alin Gherasim; Jorge Díaz-González; Caterina Rizzo; Alina Ivanciuc; Florence Galtier; Niina Ikonen; Aukse Mickiene; Verónica Gómez; S. Kurecic Filipovic; Annamária Ferenczi; M. R. Korcinska; R. van Gageldonk-Lafeber; Marta Valenciano
XXXV Reunião Anual da Sociedade Espanhola de Epidemiología (SEE) e XII Congresso da Associação Portuguesa de Epidemiologia (APE), 6-8 Septiembre 2017 | 2017
Verónica Gómez; Mafalda Sousa-Uva; Patrícia Conde; Irina Kislaya; Victor Gomes; José Poças; Raquel Guiomar; Baltazar Nunes; Ausenda Machado
XXXV Reunião Anual da Sociedade Espanhola de Epidemiología (SEE) e XII Congresso da Associação Portuguesa de Epidemiologia (APE), 6-8 Septiembre 2017 | 2017
Ausenda Machado; Irina Kislaya; Verónica Gómez; Mafalda Sousa-Uva; Ana Paula Ribeiro Rodrigues; Baltazar Nunes
V Congresso Nacional de Saúde Pública, 16-17 fevereiro 2017 | 2017
Verónica Gómez; Victor Gomes; José Poças; Rita Côrte-Real; Maria João Peres; Ana Paula Ribeiro Rodrigues; Ausenda Machado; Baltazar Nunes
Archive | 2017
Ana Paula Ribeiro Rodrigues; Irina Kislaya; Ausenda Machado; Verónica Gómez; Cristina Bárbara; Paulo Bayard Dias Gonçalves; Baltazar Nunes
IMOVE+ - tecnhical meeting, 8 junho 2017 | 2017
Ana Paula Ribeiro Rodrigues; Paulo Bayard Dias Gonçalves; Verónica Gómez; Irina Kislaya; Baltazar Nunes
XI Congresso da Associação Portuguesa de Epidemiologia, 14-16 setembro 2016 | 2016
Verónica Gómez; Ana Paula Ribeiro Rodrigues; Raquel Guiomar; Pedro Pechirra; Patrícia Conde; Paula Cristóvão; Inês Costa; Baltazar Nunes; Ausenda Machado
European Journal of Public Health | 2016
Ana Paula Rodrigues; Pedro Pechirra; Raquel Guiomar; Patrícia Conde; Verónica Gómez; Baltazar Nunes; Ausenda Machado
Collaboration
Dive into the Verónica Gómez's collaboration.
